Navigation Links
Xoft Introduces Electronic Brachytherapy Cancer Treatment Platform at ESTRO Meeting
Date:9/13/2010

BARCELONA, Spain, Sept. 13 /PRNewswire/ -- Xoft, Inc., the pioneer of localized, isotope-free radiation treatment delivered in minimally-shielded clinical settings, today announced the introduction of the Axxent® Electronic Brachytherapy, eBx™ System to physicians and distributors in Europe.  The Axxent eBx System, which delivers treatment directly to cancer sites with minimal radiation exposure to surrounding healthy tissue, treats breast, endometrial and skin cancers and Intraoperative Radiation Therapy (IORT) indications.  The announcement was made here at the 29th Annual Meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO), where Xoft is exhibiting for the first time.

Xoft recently received CE Mark Approval for the Axxent Electronic Brachytherapy System and treatment applicators, which permits sales and marketing of the System throughout the European Union. Originally FDA-cleared for the treatment of early stage breast cancer, the Axxent eBx Systems has received supplemental clearances for additional indications and for intraoperative use.  

"With major IORT and other radiation therapy studies having been conducted in Europe over the past several years, the market is primed for launch of Electronic Brachytherapy," said Rob Kirby, Xoft's Vice President of Business Development. "We are excited to formally introduce the Axxent System to European radiation oncologists at ESTRO, and we will also use the meeting to build strong distribution relationships to drive adoption throughout the EU."  

The clinical benefits of isotope-free, 50 kV radiation therapy continue to be substantiated by multiple publications.  The most recent include publication of four-year data from the TARGIT-A (Targeted Intraoperative Radiation Therapy) multicenter clinical trial, and recent Xoft clinical publications on APBI, endometrial cancer and breast IORT.  

As a platform technology, the Axxent System is designed to deliver localized, isotope-free radiation treatment in minimally-shielded clinical settings under the supervision of a radiation oncologist to help reduce recurrence of cancer and improve survival. Utilizing a proprietary miniaturized X-ray source and mobile controller, treatment can be performed without the need for a shielded room, allowing radiation oncologists and medical personnel to be present during treatment, which minimizes patient anxiety.

"With minimal exposure to healthy tissues and rapid dose fall-off that enables treatment in minimally-shielded settings, Electronic Brachytherapy delivers targeted treatment that is professionally validated and patient friendly," said Michael Klein, President and CEO of Xoft.  "Building on years of clinical experience and scientific validation since eBx was first introduced as an X-ray-based, electronic treatment option for early stage breast cancer, we are very pleased to offer this important oncology treatment platform to radiation oncologists and patients in Europe.  Delivering safe, targeted treatment for breast, endometrial, skin and other cancers, we expect eBx will continue to increase access to critical treatment as well as improve compliance and patient care."

About Xoft, Inc.

Xoft develops Electronic Brachytherapy (eBx) systems based upon miniaturized X-ray tube technology for the practice of radiation oncology in virtually any clinical setting, eliminating the need for heavily shielded environments. The Axxent® treatment platform provides a therapeutic dose of radiation directly to the region at risk with minimal radiation exposure to surrounding healthy tissue and without the logistics and costs associated with using radioactive isotopes.  FDA-cleared for treatment of early stage breast cancer, skin cancer and endometrial cancer, the Axxent System is also cleared for use in the treatment of other cancers or conditions where radiation therapy is indicated. For information, visit www.xoftinc.com.

Axxent is a registered trademark and eBx is a trademark of Xoft, Inc.


'/>"/>
SOURCE Xoft, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Open House at Gulf Coast Cancer Treatment Center Introduces Elekta Synergy® to Community
2. Laerdal Introduces SimMan Essential
3. Elsevier Introduces SciVerse, an Innovative Platform for Accelerating Science
4. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
5. China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
6. Medical Website Design Experts Aurora Information Technology Introduces Its Newest Website Launch, Muscat Eye Laser Center
7. PAREXEL Introduces Temperature Recording Solution for Study Drug Transportation, Bringing More Efficiency to Clinical Supply Chain
8. Block Engineering Introduces Family of Quantum Cascade Laser Mid-IR Spectrometers
9. Instrumentation Laboratory Introduces Fully Automated, Liquid, Ready-to-Use HemosIL® HIT-Ab(PF4-H) Assay in Europe
10. Omnicell Introduces New Omnicell Packager With WorkflowRx Software for Improved Pharmacy Efficiency
11. RoboticOncology.com: Robotic Surgeon Dr. David Samadi, MD Introduces His SMART Surgery Technique for Prostate Cancer Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... , Feb. 20, 2017   Orion Health ... its Amadeus precision medicine platform to the ... currently manages over 110 million patient records globally. ... developing cloud-based, big data solutions built on modern, scalable ... Healthcare and Life Sciences. "The AWS Cloud gives healthcare ...
(Date:2/20/2017)... -- Research and Markets has announced the addition of ... Trends - Product (RFID refrigerators and RFID freezers), Application (Diagnostic centers, ... their offering. ... The Global RFID Blood Refrigerator and Freezer Market is poised to ... This industry report analyzes the global markets for ...
(Date:2/20/2017)... 2017   Alberty   Drugs , ... has announced a significant shift in focus ... programs to servicing local Veteran Affairs Centers (VA) and ... an increased need to secure cost effective treatments for ... locally for their goods & services. "The ...
Breaking Medicine Technology:
(Date:2/19/2017)... ... ... is a set of 30 glitch distortion logo reveals made exclusively for Final Cut ... glitch reveal in just a few clicks of a mouse. Customizable glitch style effects give ... these presets to add a uniquely animated logo to any photos or videos. Its never ...
(Date:2/18/2017)... VA (PRWEB) , ... February ... ... of Change for Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, March ... , Are manufacturers looking to reduce their regulatory burden? Pay dividends in ...
(Date:2/18/2017)... Beverly Hills, California (PRWEB) , ... February 17, ... ... 273-3007, info@drvallecillos.com , drvallecillos.com , Beverly Hills plastic surgeon ... reduce subcutaneous fat cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been ...
(Date:2/18/2017)... ... 18, 2017 , ... A new directory from the Senior ... easily connect elderly veterans of America's armed forces to a range of senior ... material on this year's increase in the Veterans Pension with Aid & Attendance ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... and sustainable systems change designed to further positively impact the health and wellness ... Trustees has long considered it our duty to seriously consider releasing our assets ...
Breaking Medicine News(10 mins):